Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
CmOGD2-Mediated Ferroptosis and Iron Uptake in Citrus Canker
2026-06-15
This reference study uncovers how the Citron gene CmOGD2 enhances resistance to citrus canker by promoting iron uptake and reactive oxygen species (ROS) accumulation, triggering ferroptosis-like cell death. These findings offer mechanistic insight into plant-pathogen interactions and highlight parallels with ferroptosis research in mammalian systems.
-
LINC01278 Suppresses Uveal Melanoma via mTOR Pathway Inhibit
2026-06-14
The referenced study identifies LINC01278 as a long noncoding RNA that acts as a tumor suppressor in uveal melanoma by inducing autophagy through mTOR pathway suppression. This mechanistic insight provides a potential new target for therapeutic strategies in UM and demonstrates the utility of mTOR modulators in dissecting pathway-specific effects on tumor biology.
-
AP1903: Precision FKBP-Binding Ligand for Conditional Cell A
2026-06-13
AP1903 empowers researchers with nanomolar, tunable control over FKBP fusion protein activity for apoptosis pathway research and conditional cell ablation. Its robust compatibility with multiplexed workflows and potent, specific action make it indispensable for precise signal modulation in advanced cell-based assays.
-
Comparative In Vitro Activity of Sisomicin and Tobramycin
2026-06-12
This article examines the pivotal study by Stewart and Bodey, which assessed the in vitro efficacy of sisomicin relative to established aminoglycoside antibiotics, including tobramycin, against a broad spectrum of clinical Gram-negative and Gram-positive isolates. The findings inform antibiotic selection and resistance research protocols in microbiology.
-
BMS 309403: FABP4 Inhibitor for Atherosclerosis Research
2026-06-12
BMS 309403, a potent and selective FABP4 inhibitor, enables precise interrogation of lipid metabolism and inflammatory processes in macrophages and atherosclerosis models. Using validated protocols and troubleshooting tips, researchers can optimize workflows to dissect the CaN/FoxO1/FABP4 pathway and its therapeutic implications in cardiovascular and metabolic disease.
-
2-APB: Strategic Control of Calcium Signaling for Translatio
2026-06-11
Explore how 2-APB (2-aminoethoxydiphenyl borate) enables translational researchers to dissect and modulate intracellular calcium signaling with precision, bridging mechanistic insight and actionable strategy for models of cell injury, autophagy, and cardiovascular disease.
-
Thioredoxin System Modulates Chk1 Inhibitor Sensitivity in N
2026-06-11
This study reveals that the thioredoxin (Trx) system, via redox regulation of ribonucleotide reductase (RNR), critically determines the sensitivity of non-small cell lung cancer (NSCLC) cells to Chk1 inhibitors. These findings provide mechanistic insight into the limited clinical efficacy of Chk1 inhibitors and suggest that targeting the Trx system may enhance therapeutic outcomes.
-
TAI-1: First-in-Class Hec1 Inhibitor for Cancer Research
2026-06-10
TAI-1 is a potent, first-in-class Hec1 inhibitor that disrupts mitotic regulation and induces apoptotic cell death in cancer cells. The compound demonstrates nanomolar potency, broad anti-tumor activity, and high selectivity, making it a leading tool for cancer cell proliferation inhibition studies.
-
Lipo3K Transfection Reagent: Mechanistic Insights & Advanced
2026-06-10
Discover the scientific basis and unique advantages of Lipo3K Transfection Reagent as a lipid transfection reagent for challenging cell types. This article offers a mechanistic deep dive and practical assay guidance, setting it apart from typical transfection guides.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Next-Gen Dual-Reporter S
2026-06-09
Explore how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) revolutionizes mRNA delivery and real-time tracking with advanced dual-modality imaging. Discover unique mechanistic insights and practical protocol guidance not found in previous reviews.
-
EdU Imaging Kits (Cy3): Transforming S-Phase Detection in On
2026-06-09
Explore how EdU Imaging Kits (Cy3) are redefining cell proliferation analysis for translational cancer researchers. This article integrates mechanistic insight into S-phase DNA synthesis measurement, interprets new findings on pituitary tumor biology, and delivers strategic guidance on deploying next-generation click chemistry assays—advancing both experimental rigor and clinical impact beyond conventional methods.
-
Leucovorin Calcium in Assembloid Models: Applied Protocols &
2026-06-08
Leucovorin Calcium empowers translational cancer research by reliably protecting cells from methotrexate-induced growth suppression and enabling robust, physiologically relevant assembloid models. This guide delivers actionable protocols, troubleshooting strategies, and practical insights for maximizing reproducibility and precision in folate metabolism studies.
-
Forsythoside E Drives PKM2 Tetramerization for Sepsis Liver
2026-06-08
The reference study identifies Forsythoside E as a specific allosteric activator of PKM2 tetramerization, reprogramming macrophage metabolism toward an anti-inflammatory state and alleviating sepsis-induced liver injury in vivo. These findings introduce a robust mechanistic rationale for targeting metabolic-epigenetic axes in septic liver injury models.
-
Danazol in Translational Endocrinology: Mechanisms and Model
2026-06-07
Explore Danazol’s role in translational endocrinology, including its molecular mechanisms, unique utility in precocious puberty models, and implications for prostate cancer research. This article provides an advanced, evidence-based perspective on Danazol beyond standard protocol guides.
-
Imipramine in Cancer Research: Lipid Metabolism and Autophag
2026-06-06
Explore how Imipramine, a tricyclic antidepressant, advances cancer research through its effects on lipid metabolism and autophagy. This article offers unique, protocol-focused insights for glioma and leukemia studies, grounded in the latest lipidomics findings.